Need help finding what you are looking for?
Contact Us
PUBLISHER: QYResearch | PRODUCT CODE: 1860040
PUBLISHER: QYResearch | PRODUCT CODE: 1860040
Amifostine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global market for Amifostine was estimated to be worth US$ 52.1 million in 2024 and is forecast to a readjusted size of US$ 60.1 million by 2031 with a CAGR of 2.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Amifostine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Amifostine (Ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen under the trade name Ethyol. In 2024, global Amifostine production reached approximately 4.68 M unit, with an average global market price of around US$ 22 per unit.
The amifostine market is primarily shaped by its role as a cytoprotective agent used alongside chemotherapy and radiotherapy to reduce toxic side effects such as xerostomia and myelosuppression. Its clinical application is most notable in cancer care, particularly for head and neck cancers, though off-label exploration in other areas has also contributed to steady demand. The growing incidence of cancer worldwide, coupled with the rising adoption of supportive care therapies, supports market expansion. Additionally, increasing awareness of treatment-related quality-of-life issues and hospital protocols emphasizing patient safety have sustained the relevance of amifostine in oncology.
At the same time, the market faces headwinds from high treatment costs, limited availability in some regions, and the emergence of alternative protective agents or treatment regimens with fewer side effects. Patent expiries and the entry of generics have led to greater price competition, particularly in emerging markets where affordability drives uptake. Opportunities lie in expanding access through generics, advancing formulations to reduce adverse reactions such as hypotension and nausea, and integrating amifostine into broader supportive oncology care strategies. Overall, while niche compared to mainstream oncology drugs, the amifostine market remains stable, supported by its unique protective benefits in cancer treatment.
This report aims to provide a comprehensive presentation of the global market for Amifostine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Amifostine by region & country, by Type, and by Application.
The Amifostine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Amifostine.
Market Segmentation
By Company
- Clinigen
- Sun Pharmaceutical
- Taj Pharmaceuticals
- Merro Pharmaceutical
- Luye Pharma
- Mingren Pharma
Segment by Type
- 400mg/Dose
- 500mg/Dose
Segment by Application
- Head and Neck Cancer Adjuvant Therapy
- Others
By Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Amifostine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Amifostine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Amifostine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
- 1.1 Amifostine Product Introduction
- 1.2 Global Amifostine Market Size Forecast
- 1.2.1 Global Amifostine Sales Value (2020-2031)
- 1.2.2 Global Amifostine Sales Volume (2020-2031)
- 1.2.3 Global Amifostine Sales Price (2020-2031)
- 1.3 Amifostine Market Trends & Drivers
- 1.3.1 Amifostine Industry Trends
- 1.3.2 Amifostine Market Drivers & Opportunity
- 1.3.3 Amifostine Market Challenges
- 1.3.4 Amifostine Market Restraints
- 1.4 Assumptions and Limitations
- 1.5 Study Objectives
- 1.6 Years Considered
2 Competitive Analysis by Company
- 2.1 Global Amifostine Players Revenue Ranking (2024)
- 2.2 Global Amifostine Revenue by Company (2020-2025)
- 2.3 Global Amifostine Players Sales Volume Ranking (2024)
- 2.4 Global Amifostine Sales Volume by Company Players (2020-2025)
- 2.5 Global Amifostine Average Price by Company (2020-2025)
- 2.6 Key Manufacturers Amifostine Manufacturing Base and Headquarters
- 2.7 Key Manufacturers Amifostine Product Offered
- 2.8 Key Manufacturers Time to Begin Mass Production of Amifostine
- 2.9 Amifostine Market Competitive Analysis
- 2.9.1 Amifostine Market Concentration Rate (2020-2025)
- 2.9.2 Global 5 and 10 Largest Manufacturers by Amifostine Revenue in 2024
- 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifostine as of 2024)
- 2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
- 3.1 Introduction by Type
- 3.1.1 400mg/Dose
- 3.1.2 500mg/Dose
- 3.2 Global Amifostine Sales Value by Type
- 3.2.1 Global Amifostine Sales Value by Type (2020 VS 2024 VS 2031)
- 3.2.2 Global Amifostine Sales Value, by Type (2020-2031)
- 3.2.3 Global Amifostine Sales Value, by Type (%) (2020-2031)
- 3.3 Global Amifostine Sales Volume by Type
- 3.3.1 Global Amifostine Sales Volume by Type (2020 VS 2024 VS 2031)
- 3.3.2 Global Amifostine Sales Volume, by Type (2020-2031)
- 3.3.3 Global Amifostine Sales Volume, by Type (%) (2020-2031)
- 3.4 Global Amifostine Average Price by Type (2020-2031)
4 Segmentation by Application
- 4.1 Introduction by Application
- 4.1.1 Head and Neck Cancer Adjuvant Therapy
- 4.1.2 Others
- 4.2 Global Amifostine Sales Value by Application
- 4.2.1 Global Amifostine Sales Value by Application (2020 VS 2024 VS 2031)
- 4.2.2 Global Amifostine Sales Value, by Application (2020-2031)
- 4.2.3 Global Amifostine Sales Value, by Application (%) (2020-2031)
- 4.3 Global Amifostine Sales Volume by Application
- 4.3.1 Global Amifostine Sales Volume by Application (2020 VS 2024 VS 2031)
- 4.3.2 Global Amifostine Sales Volume, by Application (2020-2031)
- 4.3.3 Global Amifostine Sales Volume, by Application (%) (2020-2031)
- 4.4 Global Amifostine Average Price by Application (2020-2031)
5 Segmentation by Region
- 5.1 Global Amifostine Sales Value by Region
- 5.1.1 Global Amifostine Sales Value by Region: 2020 VS 2024 VS 2031
- 5.1.2 Global Amifostine Sales Value by Region (2020-2025)
- 5.1.3 Global Amifostine Sales Value by Region (2026-2031)
- 5.1.4 Global Amifostine Sales Value by Region (%), (2020-2031)
- 5.2 Global Amifostine Sales Volume by Region
- 5.2.1 Global Amifostine Sales Volume by Region: 2020 VS 2024 VS 2031
- 5.2.2 Global Amifostine Sales Volume by Region (2020-2025)
- 5.2.3 Global Amifostine Sales Volume by Region (2026-2031)
- 5.2.4 Global Amifostine Sales Volume by Region (%), (2020-2031)
- 5.3 Global Amifostine Average Price by Region (2020-2031)
- 5.4 North America
- 5.4.1 North America Amifostine Sales Value, 2020-2031
- 5.4.2 North America Amifostine Sales Value by Country (%), 2024 VS 2031
- 5.5 Europe
- 5.5.1 Europe Amifostine Sales Value, 2020-2031
- 5.5.2 Europe Amifostine Sales Value by Country (%), 2024 VS 2031
- 5.6 Asia Pacific
- 5.6.1 Asia Pacific Amifostine Sales Value, 2020-2031
- 5.6.2 Asia Pacific Amifostine Sales Value by Region (%), 2024 VS 2031
- 5.7 South America
- 5.7.1 South America Amifostine Sales Value, 2020-2031
- 5.7.2 South America Amifostine Sales Value by Country (%), 2024 VS 2031
- 5.8 Middle East & Africa
- 5.8.1 Middle East & Africa Amifostine Sales Value, 2020-2031
- 5.8.2 Middle East & Africa Amifostine Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
- 6.1 Key Countries/Regions Amifostine Sales Value Growth Trends, 2020 VS 2024 VS 2031
- 6.2 Key Countries/Regions Amifostine Sales Value and Sales Volume
- 6.2.1 Key Countries/Regions Amifostine Sales Value, 2020-2031
- 6.2.2 Key Countries/Regions Amifostine Sales Volume, 2020-2031
- 6.3 United States
- 6.3.1 United States Amifostine Sales Value, 2020-2031
- 6.3.2 United States Amifostine Sales Value by Type (%), 2024 VS 2031
- 6.3.3 United States Amifostine Sales Value by Application, 2024 VS 2031
- 6.4 Europe
- 6.4.1 Europe Amifostine Sales Value, 2020-2031
- 6.4.2 Europe Amifostine Sales Value by Type (%), 2024 VS 2031
- 6.4.3 Europe Amifostine Sales Value by Application, 2024 VS 2031
- 6.5 China
- 6.5.1 China Amifostine Sales Value, 2020-2031
- 6.5.2 China Amifostine Sales Value by Type (%), 2024 VS 2031
- 6.5.3 China Amifostine Sales Value by Application, 2024 VS 2031
- 6.6 Japan
- 6.6.1 Japan Amifostine Sales Value, 2020-2031
- 6.6.2 Japan Amifostine Sales Value by Type (%), 2024 VS 2031
- 6.6.3 Japan Amifostine Sales Value by Application, 2024 VS 2031
- 6.7 South Korea
- 6.7.1 South Korea Amifostine Sales Value, 2020-2031
- 6.7.2 South Korea Amifostine Sales Value by Type (%), 2024 VS 2031
- 6.7.3 South Korea Amifostine Sales Value by Application, 2024 VS 2031
- 6.8 Southeast Asia
- 6.8.1 Southeast Asia Amifostine Sales Value, 2020-2031
- 6.8.2 Southeast Asia Amifostine Sales Value by Type (%), 2024 VS 2031
- 6.8.3 Southeast Asia Amifostine Sales Value by Application, 2024 VS 2031
- 6.9 India
- 6.9.1 India Amifostine Sales Value, 2020-2031
- 6.9.2 India Amifostine Sales Value by Type (%), 2024 VS 2031
- 6.9.3 India Amifostine Sales Value by Application, 2024 VS 2031
7 Company Profiles
- 7.1 Clinigen
- 7.1.1 Clinigen Company Information
- 7.1.2 Clinigen Introduction and Business Overview
- 7.1.3 Clinigen Amifostine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.1.4 Clinigen Amifostine Product Offerings
- 7.1.5 Clinigen Recent Development
- 7.2 Sun Pharmaceutical
- 7.2.1 Sun Pharmaceutical Company Information
- 7.2.2 Sun Pharmaceutical Introduction and Business Overview
- 7.2.3 Sun Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.2.4 Sun Pharmaceutical Amifostine Product Offerings
- 7.2.5 Sun Pharmaceutical Recent Development
- 7.3 Taj Pharmaceuticals
- 7.3.1 Taj Pharmaceuticals Company Information
- 7.3.2 Taj Pharmaceuticals Introduction and Business Overview
- 7.3.3 Taj Pharmaceuticals Amifostine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.3.4 Taj Pharmaceuticals Amifostine Product Offerings
- 7.3.5 Taj Pharmaceuticals Recent Development
- 7.4 Merro Pharmaceutical
- 7.4.1 Merro Pharmaceutical Company Information
- 7.4.2 Merro Pharmaceutical Introduction and Business Overview
- 7.4.3 Merro Pharmaceutical Amifostine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.4.4 Merro Pharmaceutical Amifostine Product Offerings
- 7.4.5 Merro Pharmaceutical Recent Development
- 7.5 Luye Pharma
- 7.5.1 Luye Pharma Company Information
- 7.5.2 Luye Pharma Introduction and Business Overview
- 7.5.3 Luye Pharma Amifostine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.5.4 Luye Pharma Amifostine Product Offerings
- 7.5.5 Luye Pharma Recent Development
- 7.6 Mingren Pharma
- 7.6.1 Mingren Pharma Company Information
- 7.6.2 Mingren Pharma Introduction and Business Overview
- 7.6.3 Mingren Pharma Amifostine Sales, Revenue, Price and Gross Margin (2020-2025)
- 7.6.4 Mingren Pharma Amifostine Product Offerings
- 7.6.5 Mingren Pharma Recent Development
8 Industry Chain Analysis
- 8.1 Amifostine Industrial Chain
- 8.2 Amifostine Upstream Analysis
- 8.2.1 Key Raw Materials
- 8.2.2 Raw Materials Key Suppliers
- 8.2.3 Manufacturing Cost Structure
- 8.3 Midstream Analysis
- 8.4 Downstream Analysis (Customers Analysis)
- 8.5 Sales Model and Sales Channels
- 8.5.1 Amifostine Sales Model
- 8.5.2 Sales Channel
- 8.5.3 Amifostine Distributors
9 Research Findings and Conclusion
10 Appendix
- 10.1 Research Methodology
- 10.1.1 Methodology/Research Approach
- 10.1.1.1 Research Programs/Design
- 10.1.1.2 Market Size Estimation
- 10.1.1.3 Market Breakdown and Data Triangulation
- 10.1.2 Data Source
- 10.1.2.1 Secondary Sources
- 10.1.2.2 Primary Sources
- 10.1.1 Methodology/Research Approach
- 10.2 Author Details
- 10.3 Disclaimer
List of Tables
- Table 1. Amifostine Market Trends
- Table 2. Amifostine Market Drivers & Opportunity
- Table 3. Amifostine Market Challenges
- Table 4. Amifostine Market Restraints
- Table 5. Global Amifostine Revenue by Company (2020-2025) & (US$ Million)
- Table 6. Global Amifostine Revenue Market Share by Company (2020-2025)
- Table 7. Global Amifostine Sales Volume by Company (2020-2025) & (K Units)
- Table 8. Global Amifostine Sales Volume Market Share by Company (2020-2025)
- Table 9. Global Market Amifostine Price by Company (2020-2025) & (USD/Unit)
- Table 10. Key Manufacturers Amifostine Manufacturing Base and Headquarters
- Table 11. Key Manufacturers Amifostine Product Type
- Table 12. Key Manufacturers Time to Begin Mass Production of Amifostine
- Table 13. Global Amifostine Manufacturers Market Concentration Ratio (CR5 and HHI)
- Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amifostine as of 2024)
- Table 15. Mergers & Acquisitions, Expansion Plans
- Table 16. Global Amifostine Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
- Table 17. Global Amifostine Sales Value by Type (2020-2025) & (US$ Million)
- Table 18. Global Amifostine Sales Value by Type (2026-2031) & (US$ Million)
- Table 19. Global Amifostine Sales Market Share in Value by Type (2020-2025)
- Table 20. Global Amifostine Sales Market Share in Value by Type (2026-2031)
- Table 21. Global Amifostine Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
- Table 22. Global Amifostine Sales Volume by Type (2020-2025) & (K Units)
- Table 23. Global Amifostine Sales Volume by Type (2026-2031) & (K Units)
- Table 24. Global Amifostine Sales Market Share in Volume by Type (2020-2025)
- Table 25. Global Amifostine Sales Market Share in Volume by Type (2026-2031)
- Table 26. Global Amifostine Price by Type (2020-2025) & (USD/Unit)
- Table 27. Global Amifostine Price by Type (2026-2031) & (USD/Unit)
- Table 28. Global Amifostine Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
- Table 29. Global Amifostine Sales Value by Application (2020-2025) & (US$ Million)
- Table 30. Global Amifostine Sales Value by Application (2026-2031) & (US$ Million)
- Table 31. Global Amifostine Sales Market Share in Value by Application (2020-2025)
- Table 32. Global Amifostine Sales Market Share in Value by Application (2026-2031)
- Table 33. Global Amifostine Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
- Table 34. Global Amifostine Sales Volume by Application (2020-2025) & (K Units)
- Table 35. Global Amifostine Sales Volume by Application (2026-2031) & (K Units)
- Table 36. Global Amifostine Sales Market Share in Volume by Application (2020-2025)
- Table 37. Global Amifostine Sales Market Share in Volume by Application (2026-2031)
- Table 38. Global Amifostine Price by Application (2020-2025) & (USD/Unit)
- Table 39. Global Amifostine Price by Application (2026-2031) & (USD/Unit)
- Table 40. Global Amifostine Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
- Table 41. Global Amifostine Sales Value by Region (2020-2025) & (US$ Million)
- Table 42. Global Amifostine Sales Value by Region (2026-2031) & (US$ Million)
- Table 43. Global Amifostine Sales Value by Region (2020-2025) & (%)
- Table 44. Global Amifostine Sales Value by Region (2026-2031) & (%)
- Table 45. Global Amifostine Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
- Table 46. Global Amifostine Sales Volume by Region (2020-2025) & (K Units)
- Table 47. Global Amifostine Sales Volume by Region (2026-2031) & (K Units)
- Table 48. Global Amifostine Sales Volume by Region (2020-2025) & (%)
- Table 49. Global Amifostine Sales Volume by Region (2026-2031) & (%)
- Table 50. Global Amifostine Average Price by Region (2020-2025) & (USD/Unit)
- Table 51. Global Amifostine Average Price by Region (2026-2031) & (USD/Unit)
- Table 52. Key Countries/Regions Amifostine Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
- Table 53. Key Countries/Regions Amifostine Sales Value, (2020-2025) & (US$ Million)
- Table 54. Key Countries/Regions Amifostine Sales Value, (2026-2031) & (US$ Million)
- Table 55. Key Countries/Regions Amifostine Sales Volume, (2020-2025) & (K Units)
- Table 56. Key Countries/Regions Amifostine Sales Volume, (2026-2031) & (K Units)
- Table 57. Clinigen Company Information
- Table 58. Clinigen Introduction and Business Overview
- Table 59. Clinigen Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
- Table 60. Clinigen Amifostine Product Offerings
- Table 61. Clinigen Recent Development
- Table 62. Sun Pharmaceutical Company Information
- Table 63. Sun Pharmaceutical Introduction and Business Overview
- Table 64. Sun Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
- Table 65. Sun Pharmaceutical Amifostine Product Offerings
- Table 66. Sun Pharmaceutical Recent Development
- Table 67. Taj Pharmaceuticals Company Information
- Table 68. Taj Pharmaceuticals Introduction and Business Overview
- Table 69. Taj Pharmaceuticals Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
- Table 70. Taj Pharmaceuticals Amifostine Product Offerings
- Table 71. Taj Pharmaceuticals Recent Development
- Table 72. Merro Pharmaceutical Company Information
- Table 73. Merro Pharmaceutical Introduction and Business Overview
- Table 74. Merro Pharmaceutical Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
- Table 75. Merro Pharmaceutical Amifostine Product Offerings
- Table 76. Merro Pharmaceutical Recent Development
- Table 77. Luye Pharma Company Information
- Table 78. Luye Pharma Introduction and Business Overview
- Table 79. Luye Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
- Table 80. Luye Pharma Amifostine Product Offerings
- Table 81. Luye Pharma Recent Development
- Table 82. Mingren Pharma Company Information
- Table 83. Mingren Pharma Introduction and Business Overview
- Table 84. Mingren Pharma Amifostine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
- Table 85. Mingren Pharma Amifostine Product Offerings
- Table 86. Mingren Pharma Recent Development
- Table 87. Key Raw Materials Lists
- Table 88. Raw Materials Key Suppliers Lists
- Table 89. Amifostine Downstream Customers
- Table 90. Amifostine Distributors List
- Table 91. Research Programs/Design for This Report
- Table 92. Key Data Information from Secondary Sources
- Table 93. Key Data Information from Primary Sources
List of Figures
- Figure 1. Amifostine Product Picture
- Figure 2. Global Amifostine Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
- Figure 3. Global Amifostine Sales Value (2020-2031) & (US$ Million)
- Figure 4. Global Amifostine Sales Volume (2020-2031) & (K Units)
- Figure 5. Global Amifostine Sales Price (2020-2031) & (USD/Unit)
- Figure 6. Amifostine Report Years Considered
- Figure 7. Global Amifostine Players Revenue Ranking (2024) & (US$ Million)
- Figure 8. Global Amifostine Players Sales Volume Ranking (2024) & (K Units)
- Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Amifostine Revenue in 2024
- Figure 10. Amifostine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
- Figure 11. 400mg/Dose Picture
- Figure 12. 500mg/Dose Picture
- Figure 13. Global Amifostine Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 14. Global Amifostine Sales Value Market Share by Type, 2024 & 2031
- Figure 15. Global Amifostine Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
- Figure 16. Global Amifostine Sales Volume Market Share by Type, 2024 & 2031
- Figure 17. Global Amifostine Price by Type (2020-2031) & (USD/Unit)
- Figure 18. Product Picture of Head and Neck Cancer Adjuvant Therapy
- Figure 19. Product Picture of Others
- Figure 20. Global Amifostine Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
- Figure 21. Global Amifostine Sales Value Market Share by Application, 2024 & 2031
- Figure 22. Global Amifostine Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
- Figure 23. Global Amifostine Sales Volume Market Share by Application, 2024 & 2031
- Figure 24. Global Amifostine Price by Application (2020-2031) & (USD/Unit)
- Figure 25. North America Amifostine Sales Value (2020-2031) & (US$ Million)
- Figure 26. North America Amifostine Sales Value by Country (%), 2024 VS 2031
- Figure 27. Europe Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 28. Europe Amifostine Sales Value by Country (%), 2024 VS 2031
- Figure 29. Asia Pacific Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 30. Asia Pacific Amifostine Sales Value by Region (%), 2024 VS 2031
- Figure 31. South America Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 32. South America Amifostine Sales Value by Country (%), 2024 VS 2031
- Figure 33. Middle East & Africa Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 34. Middle East & Africa Amifostine Sales Value by Country (%), 2024 VS 2031
- Figure 35. Key Countries/Regions Amifostine Sales Value (%), (2020-2031)
- Figure 36. Key Countries/Regions Amifostine Sales Volume (%), (2020-2031)
- Figure 37. United States Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 38. United States Amifostine Sales Value by Type (%), 2024 VS 2031
- Figure 39. United States Amifostine Sales Value by Application (%), 2024 VS 2031
- Figure 40. Europe Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 41. Europe Amifostine Sales Value by Type (%), 2024 VS 2031
- Figure 42. Europe Amifostine Sales Value by Application (%), 2024 VS 2031
- Figure 43. China Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 44. China Amifostine Sales Value by Type (%), 2024 VS 2031
- Figure 45. China Amifostine Sales Value by Application (%), 2024 VS 2031
- Figure 46. Japan Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 47. Japan Amifostine Sales Value by Type (%), 2024 VS 2031
- Figure 48. Japan Amifostine Sales Value by Application (%), 2024 VS 2031
- Figure 49. South Korea Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 50. South Korea Amifostine Sales Value by Type (%), 2024 VS 2031
- Figure 51. South Korea Amifostine Sales Value by Application (%), 2024 VS 2031
- Figure 52. Southeast Asia Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 53. Southeast Asia Amifostine Sales Value by Type (%), 2024 VS 2031
- Figure 54. Southeast Asia Amifostine Sales Value by Application (%), 2024 VS 2031
- Figure 55. India Amifostine Sales Value, (2020-2031) & (US$ Million)
- Figure 56. India Amifostine Sales Value by Type (%), 2024 VS 2031
- Figure 57. India Amifostine Sales Value by Application (%), 2024 VS 2031
- Figure 58. Amifostine Industrial Chain
- Figure 59. Amifostine Manufacturing Cost Structure
- Figure 60. Channels of Distribution (Direct Sales, and Distribution)
- Figure 61. Bottom-up and Top-down Approaches for This Report
- Figure 62. Data Triangulation
- Figure 63. Key Executives Interviewed
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.